KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter. The US...
Nirma issues bonds to fund Glenmark Life Sciences acquisition: Bankers
India’s Nirma has accepted bids aggregating to 35 billion rupees ($422 million) for a three-part shorter-tenor bonds to fund its acquisition of a 75% stake in Glenmark Pharma’s life sciences unit, three...
Sun Pharma to acquire 16.33 pc stake in Surgimatix for USD 3.05 mn
Sun Pharmaceutical Industries Ltd said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm for USD 3.05 million (over Rs 25 crore). Surgimatix is engaged in the business of developing a...
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions. GSK will pay $1 billion upfront and up to $400 million...
Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 cr
Eris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parenterals is a leading player in the sterile injectables business in over 80...
ChrysCapital close to acquiring 5-6% in pharma co La Renon Healthcare
Homegrown private equity fund ChrysCapital is close to acquiring 5-6% stake in pharmaceutical company La Renon Healthcare via secondary sale of shares at an estimated valuation of ₹6,500 crore, or $800 million, multiple...
Thyrocare to buy home ECG service provider Think Health
Pharmeasy-backed diagnostic provider Thyrocare, said it will be acquiring 100% stake in Chennai-based Think Health Diagnostics to enter into providing electrocardiogram (ECG) services at home. The financial details of...
Novartis to acquire cancer-focused MorphoSys for $2.9 billion
Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment candidate to its portfolio. Reuters...
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Hong Kong-listed Sino Biopharmaceutical will sell a 67% stake in unit CP Pharmaceutical (Qingdao) for 1.82 billion yuan ($253.28 million) to entities controlled by state-owned Guoxin Group, the company said late on...
Novartis in the lead to acquire cancer drug developer MorphoSys – sources
Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar with the matter said on Monday...
ADIA, HarbourVest eye minor stake in Cohance
The Abu Dhabi Investment Authority (ADIA), the sovereign wealth fund of the oil-rich emirate, along with London-based private equity fund HarbourVest, is in discussions to acquire a minority stake in Cohance...
India’s Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln
India’s Sun Pharmaceutical Industries Limited said on Wednesday it would buy all the shares of Taro Pharmaceutical Industries it does not already own for $43 per share in cash, effectively taking full control of...
